Comparison of structural proteins among antigenically different Japanese encephalitis virus strains

Vaccine ◽  
1994 ◽  
Vol 12 (9) ◽  
pp. 841-844 ◽  
Author(s):  
H HASEGAWA ◽  
M YOSHIDA ◽  
S FUJITA ◽  
Y KOBAYASHI
2004 ◽  
Vol 85 (2) ◽  
pp. 471-482 ◽  
Author(s):  
Priti Kumar ◽  
Venkatramana D. Krishna ◽  
Paramadevanapalli Sulochana ◽  
Gejjehalli Nirmala ◽  
Maganti Haridattatreya ◽  
...  

Japanese encephalitis virus (JEV), a single-stranded positive-sense RNA virus of the family Flaviviridae, is the major cause of paediatric encephalitis in Asia. The high incidence of subclinical infections in Japanese encephalitis-endemic areas and subsequent evasion of encephalitis points to the development of immune responses against JEV. Humoral responses play a central role in protection against JEV; however, cell-mediated immune responses contributing to this end are not fully understood. The structural envelope (E) protein, the major inducer of neutralizing antibodies, is a poor target for T cells in natural JEV infections. The extent to which JEV non-structural proteins are targeted by T cells in subclinically infected healthy children would help to elucidate the role of cell-mediated immunity in protection against JEV as well as other flaviviral infections. The property of the Tat peptide of Human immunodeficiency virus to transduce proteins across cell membranes, facilitating intracellular protein delivery following exogenous addition to cultured cells, prompted us to express the four largest proteins of JEV, comprising 71 % of the JEV genome coding sequence, as Tat fusions for enumerating the frequencies of virus-specific CD4+ and CD8+ T cells in JEV-immune donors. At least two epitopes recognized by distinct HLA alleles were found on each of the non-structural proteins, with dominant antiviral Th1 T cell responses to the NS3 protein in nearly 96 % of the cohort. The data presented here show that non-structural proteins are frequently targeted by T cells in natural JEV infections and may be efficacious supplements for the predominantly antibody-eliciting E-based JEV vaccines.


Vaccine ◽  
2004 ◽  
Vol 22 (27-28) ◽  
pp. 3722-3726 ◽  
Author(s):  
David W.C Beasley ◽  
Li Li ◽  
Miguel T Suderman ◽  
Farshad Guirakhoo ◽  
Dennis W Trent ◽  
...  

1995 ◽  
Vol 140 (9) ◽  
pp. 1557-1575 ◽  
Author(s):  
A. Ali ◽  
A. Igarashi ◽  
L. R. Paneru ◽  
F. Hasebe ◽  
K. Morita ◽  
...  

2006 ◽  
Vol 87 (11) ◽  
pp. 3131-3140 ◽  
Author(s):  
Thomas J. Chambers ◽  
Xiaoshan Jiang ◽  
Deborah A. Droll ◽  
Yan Liang ◽  
William S. M. Wold ◽  
...  

A molecular clone of Japanese encephalitis virus (JE virus) was derived from the JE virus Nakayama strain and used to produce infectious JE virus in cell culture. The engineered JE virus resembled the parental JE virus in cell-culture properties and was related closely to other JE virus strains based on nucleotide sequence analysis. The JE virus clone was used as a genetic background for construction of a chimeric virus containing the structural proteins prM and E of Dengue virus, serotype 2. The chimeric JE/dengue 2 virus generated authentic dengue 2 structural proteins as assessed by immunoassays for the dengue E protein. It exhibited a small plaque size and less efficient growth in various cell lines than the parental JE virus. JE/dengue 2 virus was non-neuroinvasive for young adult mice, but displayed partial neurovirulence at doses up to 4 log p.f.u. given intracerebrally. Immunization of 3-week-old mice with JE/dengue 2 virus yielded neutralizing-antibody titres against dengue 2 virus and conferred protection against dengue encephalitis caused by neuroadapted dengue 2 virus. A rise in post-challenge neutralizing-antibody titres against dengue 2 virus in surviving mice suggests that immunization is associated with establishment of a memory antibody response in this model. This study demonstrates the capacity of JE virus to serve as a vector for expression of heterologous flavivirus structural proteins. Similar to previous studies with other chimeric flaviviruses, this approach may be useful as a genetic system for engineering experimental vaccines against Dengue virus and other medically important flaviviruses.


Sign in / Sign up

Export Citation Format

Share Document